Abstract
Regulatory T (Treg) cells play an important role in the maintenance of self-tolerance and are involved in the prevention of autoimmune diseases and reduce/inhibit the progression of chronic inflammatory diseases. Forkhead box P3 (FoxP3) expression in Treg cells is believed to be a critical factor in the maintenance of Treg cells suppressive function. Multiple mechanisms of action of Treg cells have been proposed, including cell contact – dependent and cytokinedependent mechanisms. However, no clear picture is available to fully elucidate the regulation of FoxP3 gene expression in Treg cells and how FoxP3-expressing Treg cells mediate the immune response in vivo. This review will discuss the research advancements in Treg cell biology including the transcription factors and signaling pathways involved in the expression of FoxP3 gene as well as the advancements in the understanding of the factors involved in the Treg cell-mediated suppressive mechanisms.
Keywords: cell differentiation, FoxP3, immune regulation, Regulatory T cells, signal transduction, Activation-induced cell death, Activator protein, Antigen presenting cells, Activating transcription factor, B cell lymphoma/leukemia 10, CARD-containing MAGUK protein 1
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title: The Regulation of FoxP3-Expressing Regulatory T Cells
Volume: 11 Issue: 4
Author(s): Rizwanul Haque, Fengyang Lei, Xiaofang Xiong and Jianxun Song
Affiliation:
Keywords: cell differentiation, FoxP3, immune regulation, Regulatory T cells, signal transduction, Activation-induced cell death, Activator protein, Antigen presenting cells, Activating transcription factor, B cell lymphoma/leukemia 10, CARD-containing MAGUK protein 1
Abstract: Regulatory T (Treg) cells play an important role in the maintenance of self-tolerance and are involved in the prevention of autoimmune diseases and reduce/inhibit the progression of chronic inflammatory diseases. Forkhead box P3 (FoxP3) expression in Treg cells is believed to be a critical factor in the maintenance of Treg cells suppressive function. Multiple mechanisms of action of Treg cells have been proposed, including cell contact – dependent and cytokinedependent mechanisms. However, no clear picture is available to fully elucidate the regulation of FoxP3 gene expression in Treg cells and how FoxP3-expressing Treg cells mediate the immune response in vivo. This review will discuss the research advancements in Treg cell biology including the transcription factors and signaling pathways involved in the expression of FoxP3 gene as well as the advancements in the understanding of the factors involved in the Treg cell-mediated suppressive mechanisms.
Export Options
About this article
Cite this article as:
Haque Rizwanul, Lei Fengyang, Xiong Xiaofang and Song Jianxun, The Regulation of FoxP3-Expressing Regulatory T Cells, Endocrine, Metabolic & Immune Disorders - Drug Targets 2011; 11 (4) . https://dx.doi.org/10.2174/187153011797881157
DOI https://dx.doi.org/10.2174/187153011797881157 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Oligonucleotides and Oligonucleotide Conjugates: A New Approach for Cancer Treatment
Current Medicinal Chemistry Synthetic Approaches to Functionalized Lipids for Protein Monolayer Crystallizations
Current Organic Chemistry Bortezomib: A New Pro-Apoptotic Agent in Cancer Treatment
Current Cancer Drug Targets S100A8/A9 as a Pro-inflammatory Cytokine in Obstructive Airway Disease Via the Multi-Ligand Receptor, RAGE
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Lymphatics and Inflammation
Current Medicinal Chemistry Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives
Current Drug Targets Trends in Malignant Glioma Monoclonal Antibody Therapy
Current Cancer Therapy Reviews Insights into the Structural Features Essential for JAK2 Inhibition and Selectivity
Current Medicinal Chemistry The Interactions of Anti-Cancer Drugs Approved in the Last Decade in the United States with Membrane Transporters
Anti-Cancer Agents in Medicinal Chemistry PARP1: A Promising Target for the Development of PARP1-based Candidates for Anticancer Intervention
Current Medicinal Chemistry Folate Based Radiopharmaceuticals for Imaging and Therapy of Cancer and Inflammation
Current Pharmaceutical Design Quantum Dots in the Therapy: Current Trends and Perspectives
Mini-Reviews in Medicinal Chemistry Current Perspective of Natural Alkaloid Carbazole and its Derivatives as Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry Making the Most of Pathological Specimens: Molecular Diagnosis in Formalin-Fixed, Paraffin Embedded Tissue
Current Drug Targets Measles Virus as An Oncolytic Vector Platform
Current Gene Therapy Recent Patents on the Identification and Clinical Application of microRNAs and Target Genes
Recent Patents on DNA & Gene Sequences Mouse Models of Primary Sjogren’s Syndrome
Current Pharmaceutical Design Rheumatoid Arthritis: Conjugating Basics with Drug Delivery
Current Rheumatology Reviews Mechanisms for Targeted Delivery of Nanoparticles in Cancer
Current Pharmaceutical Design Molecular Basis for Designing Selective Modulators of Retinoic Acid Receptor Transcriptional Activities
Current Drug Targets - Immune, Endocrine & Metabolic Disorders